Results 31 to 40 of about 16,357 (163)

经导管二尖瓣瓣中瓣置换术治疗生物瓣衰败患者随访观察

open access: yes浙江大学学报. 医学版
目的评估经导管二尖瓣瓣中瓣置换术(ViV-TMVR)置入SAPIEN 3瓣膜治疗二尖瓣生物瓣衰败患者的1年随访结果。方法回顾性分析2022年11月至2024年7月在四川大学华西医院接受ViV-TMVR治疗的26例二尖瓣生物瓣衰败患者的临床资料。患者年龄为71.5(64.5,74.5)岁,69.2%为女性。外科生物瓣置入(9.7±3.7)年后发生衰败,最常见的类型是狭窄合并反流(53.8%)。经房间隔或心尖入路置入生物瓣,于患者术前、术后即刻,以及术后1、6个月和1年进行超声心动图检查 ...
冉 泽超   +7 more
doaj   +1 more source

WHO cardiovascular disease risk prediction model performance in 10 regions, China [PDF]

open access: yes, 2023
Objective To validate the World Health Organization (WHO) non-laboratory-based cardiovascular disease risk prediction model in regions of China. Methods We performed an external validation of the WHO model for East Asia using the data set of China ...
Bennett, Derrick   +18 more
core   +2 more sources

Research Progress on the Influence of Intermittent Fasting on Cardiovascular Disease Risk Factors [PDF]

open access: yes, 2022
In recent years, the prevalence and mortality of cardiovascular diseases in China have shown a significant upward trend, cardiovascular disease has become a major disease endangering the health of Chinese residents.
CUI Yanru, CEN Qiuyu, WEI Juanfang, WANG Wenchun, ZHANG Anren
core   +1 more source

Studies of the regulatory mechanism on myocardial related genes of Rbm24 [PDF]

open access: yes, 2015
实验目的 研究在心肌细胞分化和发育过程中,Rbm24蛋白发挥功能和产生的影响。寻找Rbm24结合的相关基因的不同水平的RNA,以及结合目的RNA后所发挥的功能,为降低Rbm24的表达导致扩张性心肌病等一系列心肌受损和功能紊乱相关疾病探究原因,寻找相关的信号通路,提供一定的实验及理论依据,为成功解决心脏疾病难题寻找重要的攻克点。 方法 通过Westernblot免疫印迹检测Rbm24和其他心肌相关蛋白在C2C12细胞分化中蛋白的表达情况 ...
杨康
core  

Association of maternal body mass index with hemodynamic and vascular alterations at 35–37 weeks' gestation

open access: yesUltrasound in Obstetrics &Gynecology, Volume 65, Issue 3, Page 303-310, March 2025.
ABSTRACT Objective Globally, one in four pregnant women is classified as overweight or obese, based on their prepregnancy body mass index (BMI). Obese pregnant women are at increased risk of adverse pregnancy outcomes and long‐term cardiovascular disease that occurs earlier in life.
M. Charakida   +6 more
wiley   +1 more source

Exploring pathophysiological insights to improve diagnostic utility of ultrasound markers for distinguishing placenta accreta spectrum from uterine‐scar dehiscence

open access: yesUltrasound in Obstetrics &Gynecology, Volume 65, Issue 1, Page 85-93, January 2025.
ABSTRACT Objective Accurate differentiation between placenta accreta spectrum (PAS) and uterine‐scar dehiscence with underlying non‐adherent placenta is often challenging, even for PAS experts, both prenatally and intraoperatively. We investigated the use of standardized two‐dimensional grayscale ultrasound and Doppler imaging markers in ...
T. Adu‐Bredu   +3 more
wiley   +1 more source

Enduring inequalities: Revascularization before and after the ACA 持久的不平等:《平价医疗法案》前后的血运重建 Desigualdades duraderas: Revascularización antes y después de la ACA

open access: yesWorld Medical &Health Policy, Volume 16, Issue 4, Page 618-629, December 2024.
Abstract The use of revascularization (coronary artery bypass surgery [CABG] and percutaneous coronary intervention [PCI]) in the United States is declining, but they remain important procedures for the treatment of patients with coronary artery disease.
Michael K. Gusmano   +3 more
wiley   +1 more source

Effects of Cinacalcet HCl on Secondary Hyperparathyroidism and Renal Injury in the Uremic Rat [PDF]

open access: yes, 2016
目的 慢性肾脏病患者随着肾脏功能的逐渐减退,早期即可出现钙磷失衡、维生素D缺乏、甲状旁腺激素以及成纤维生长因子FGF23的升高,而这种矿物质代谢紊乱又可促使患者出现继发性甲状旁腺功能亢进以及加重肾脏损伤。目前CaSR激动剂作为有效抑制甲状旁腺增生的临床药物,适用于已发生SHPT的透析患者,为探究其是否也能防治继发性甲状旁腺亢进、矿物质代谢紊乱及肾脏损伤,本研究通过5/6肾大部切除术结合高磷饮食建立尿毒症大鼠模型,分别在造模成功早期预防性给予大鼠西那卡塞干预以及在大鼠慢性肾衰确立后给予盐酸西那卡塞干预 ...
孙青宜
core  

长链非编码RNA与心血管疾病的研究进展

open access: yesZhongguo shiyan zhenduanxue, 2017
目前,心血管疾病已经成为了严重威胁人类生命健康的重大慢性疾病之一。尽管日益发展的医疗技术使心血管疾病的患者经过医治后,症状能够得到一定的缓解,生活质量得到改善,但是至今仍无法从根本上使心血管疾病得到逆转或终止其进一步发展。不仅如此,相比于过去几十年,人类新的不良生活习惯也渐渐成为心血管疾病新的危险因素 ...
赵洋   +4 more
doaj  

胰高血糖素样肽-1受体激动剂对2型糖尿病合并冠心病患者心功能的影响

open access: yesZhongguo shiyan zhenduanxue, 2020
2型糖尿病(T2DM)是一组以胰岛素相对或绝对分泌不足或作用缺陷为特点的疾病。作为其最常见的并发症,冠心病等大血管病变是导致患者死亡的最主要原因,约占糖尿病患者死亡人数的70%以上,在成年人中发生心血管疾病(CVD)死亡事件的风险比正常人群高出2倍以上[1]。因此,在血糖控制良好基础上,改善心血管不良事件,降低心血管疾病的发病率和死亡率是我们亟待解决的问题。而胰高血糖素样肽-1受体激动剂(GLP-1RA ...
李晶晶, 孙立娟
doaj  

Home - About - Disclaimer - Privacy